LUCD logo

LUCD
Lucid Diagnostics Inc

1,764
Mkt Cap
$166.05M
Volume
860,551.00
52W High
$1.80
52W Low
$0.7501
PE Ratio
-1.16
LUCD Fundamentals
Price
$1.11
Prev Close
$1.21
Open
$1.19
50D MA
$1.16
Beta
0.52
Avg. Volume
1.18M
EPS (Annual)
-$1.05
P/B
-2.65
Rev/Employee
$60,361.11
Loading...
Loading...
News
all
press releases
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 PR Newswire NEW YORK, Oct. 30, 2025...
PR Newswire·5d ago
News Placeholder
More News
News Placeholder
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire...
PR Newswire·6d ago
News Placeholder
What Makes Lucid Diagnostics Inc. (LUCD) a Strong Momentum Stock: Buy Now?
Does Lucid Diagnostics Inc. (LUCD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·19d ago
News Placeholder
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire NEW YORK, Oct. 15, 2025 NEW YORK, Oct. 15, 2025...
PR Newswire·20d ago
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates
Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -11.11% and +29.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of +31.82% and +1.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -5.69% and -2.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
Hologic (HOLX) delivered earnings and revenue surprises of +2.86% and +1.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates
Zacks·6mo ago

Latest LUCD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.